Orange Book product · Generic (ANDA)
PLERIXAFOR
PLERIXAFOR
At a glance
Jul 24, 2023
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 24, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
PLERIXAFOR
Strength
24MG/1.2ML (20MG/ML)
Dosage form
SOLUTION
Route
SUBCUTANEOUS
TE code
Not listed
Application
ANDA 205197
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PLERIXAFOR
- 2008MOZOBILBrand (NDA)
NDA 022311 · GENZYME
- 2025PLERIXAFORGeneric (ANDA)
ANDA 217560 · HETERO LABS LTD VI
- 2024PLERIXAFORGeneric (ANDA)
ANDA 206644 · GLAND
- 2023PLERIXAFORGeneric (ANDA)
ANDA 208980 · ZYDUS PHARMS
- 2023PLERIXAFORGeneric (ANDA)
ANDA 215334 · AMNEAL
- 2023PLERIXAFORGeneric (ANDA)
ANDA 205182 · DR REDDYS
- 2023PLERIXAFORGeneric (ANDA)
ANDA 213672 · EUGIA PHARMA
- 2023PLERIXAFORGeneric (ANDA)
ANDA 215698 · MEITHEAL
- 2023PLERIXAFORGeneric (ANDA)
ANDA 211901 · MSN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
